Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Successful Prediction of a Left Nonrecurrent Laryngeal Nerve in a Patient With Right-Sided Aorta and Aberrant Left Subclavian Artery.

Hua X, Diggelmann H, Jalukar V, Turek JW, Pagedar NA.

Ann Otol Rhinol Laryngol. 2018 Feb;127(2):124-127. doi: 10.1177/0003489417744318. Epub 2017 Dec 4.

PMID:
29199443
2.
3.

Healing septal perforations by secondary intention using acellular dermis as a bioscaffold.

Sharma A, Janus J, Diggelmann HR, Hamilton GS 3rd.

Ann Otol Rhinol Laryngol. 2015 Jun;124(6):425-9. doi: 10.1177/0003489414565002. Epub 2014 Dec 22.

PMID:
25533508
4.

Development of a preliminary pediatric tracheal growth model from magnetic resonance images.

Amendola RL, Reinhardt JM, Zimmerman MB, Sato Y, Diggelmann HR, Kacmarynski DS.

Laryngoscope. 2014 Aug;124(8):1947-51. doi: 10.1002/lary.24547. Epub 2014 Jan 17.

PMID:
24307560
5.

Suction modulation for the laryngeal microdebrider.

Walker P, Diggelmann H, Ropp BY, Hanson JA, Hoffman HT.

Laryngoscope. 2013 Jun;123(6):1496-9. doi: 10.1002/lary.23869. Epub 2013 Apr 2. No abstract available.

PMID:
23553177
6.

Radiology quiz case 1. Iodine 131–induced sialadenitis.

Choi N, Schularick N, Diggelmann H, Smoker W, Hoffman H.

Arch Otolaryngol Head Neck Surg. 2012 Jun;138(6):597-8. doi: 10.1001/archoto.2012.429. No abstract available.

PMID:
22710514
7.

Insular thyroid carcinoma in a patient with Cowden syndrome.

Diggelmann HR, Van Daele DJ, O'Dorisio TM, Hoffman HT.

Laryngoscope. 2010 Mar;120(3):454-7. doi: 10.1002/lary.20507.

PMID:
20025044
8.

The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study.

Clark JJ, Provenzano M, Diggelmann HR, Xu N, Hansen SS, Hansen MR.

Otol Neurotol. 2008 Sep;29(6):846-53. doi: 10.1097/MAO.0b013e31817f7398.

9.

Regions of mouse mammary tumor virus superantigen involved in interaction with the major histocompatibility complex class II I-A molecule.

Wirth S, Vessaz A, Krummenacher C, Baribaud F, Acha-Orbea H, Diggelmann H.

J Virol. 2002 Nov;76(21):11172-5.

10.

Testing mouse mammary tumor virus superantigen as adjuvant in cytotoxic T-lymphocyte responses against a melanoma tumor antigen.

Wirth S, Bille F, Koenig S, Wehrli N, Miconnet I, Lévy F, Diggelmann H, Romero P, Acha-Orbea H.

Int J Cancer. 2002 May 10;99(2):201-6.

11.
12.

Extrafollicular plasmablast B cells play a key role in carrying retroviral infection to peripheral organs.

Finke D, Baribaud F, Diggelmann H, Acha-Orbea H.

J Immunol. 2001 May 15;166(10):6266-75.

13.
14.

Gene transfer into stimulated and unstimulated T lymphocytes by HIV-1-derived lentiviral vectors.

Costello E, Munoz M, Buetti E, Meylan PR, Diggelmann H, Thali M.

Gene Ther. 2000 Apr;7(7):596-604.

15.

Role of dendritic cells in the immune response induced by mouse mammary tumor virus superantigen.

Baribaud F, Maillard I, Vacheron S, Brocker T, Diggelmann H, Acha-Orbea H.

J Virol. 1999 Oct;73(10):8403-10.

16.

Preferential binding of mouse mammary tumor virus to B lymphocytes.

Baribaud F, Shaw AV, Scarpellino L, Diggelmann H, Acha-Orbea H.

J Virol. 1999 Sep;73(9):7899-902.

17.

B cell response after MMTV infection: extrafollicular plasmablasts represent the main infected population and can transmit viral infection.

Ardavín C, Martín P, Ferrero I, Azcoitia I, Anjuère F, Diggelmann H, Luthi F, Luther S, Acha-Orbea H.

J Immunol. 1999 Mar 1;162(5):2538-45.

18.

Differential reactivity of TCR Vbeta10 alleles to a mouse mammary tumor virus superantigen.

Maillard I, Xenarios I, Diggelmann H, Orbea HA.

Eur J Immunol. 1998 Oct;28(10):3075-85.

19.

Immune response to mouse mammary tumor virus in mice lacking the alpha/beta interferon or the gamma interferon receptor.

Maillard I, Launois P, Xenarios I, Louis JA, Acha-Orbea H, Diggelmann H.

J Virol. 1998 Apr;72(4):2638-46.

20.

Retrovirus-induced target cell activation in the early phases of infection: the mouse mammary tumor virus model.

Ardavin C, Luthi F, Andersson M, Scarpellino L, Martin P, Diggelmann H, Acha-Orbea H.

J Virol. 1997 Oct;71(10):7295-9.

21.

Early neutralizing antibody response against mouse mammary tumor virus: critical role of viral infection and superantigen-reactive T cells.

Luther SA, Maillard I, Luthi F, Scarpellino L, Diggelmann H, Acha-Orbea H.

J Immunol. 1997 Sep 15;159(6):2807-14.

PMID:
9300703
22.

IL-4 rapidly produced by V beta 4 V alpha 8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice.

Launois P, Maillard I, Pingel S, Swihart KG, Xénarios I, Acha-Orbea H, Diggelmann H, Locksley RM, MacDonald HR, Louis JA.

Immunity. 1997 May;6(5):541-9.

23.

Role of the immune response induced by superantigens in the pathogenesis of microbial infections.

Maillard I, Luthi F, Acha-Orbea H, Diggelmann H.

Parasitology. 1997;115 Suppl:S67-78. Review.

PMID:
9571692
24.

Involvement of the Tpl-2/cot oncogene in MMTV tumorigenesis.

Erny KM, Peli J, Lambert JF, Muller V, Diggelmann H.

Oncogene. 1996 Nov 7;13(9):2015-20.

PMID:
8934549
25.

[Studies on prion diseases].

Diggelmann H.

Rev Med Suisse Romande. 1996 Sep;116(9):751-3. French. No abstract available.

PMID:
8966477
26.

A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus.

Maillard I, Erny K, Acha-Orbea H, Diggelmann H.

Eur J Immunol. 1996 May;26(5):1000-6.

PMID:
8647159
27.

In vivo effects of a recombinant vaccinia virus expressing a mouse mammary tumor virus superantigen.

Krummenacher C, Diggelmann H, Acha-Orbea H.

J Virol. 1996 May;70(5):3026-31.

28.

The 3' half of the mouse mammary tumor virus orf gene is not sufficient for its superantigen function in transgenic mice.

Lambert JF, Acha-Orbea H, Kolb E, Diggelmann H.

Mol Immunol. 1993 Nov;30(16):1399-404.

PMID:
8232325
29.
30.
31.
32.

Expression of the mouse mammary tumor virus ORF gene in cultured cells.

Blöchlinger K, Diggelmann H.

Int Rev Immunol. 1992;8(4):337-55. Review.

PMID:
1318937
34.

Cellular and tumoural heterogeneity of EGFR gene amplification in human malignant gliomas.

Strommer K, Hamou MF, Diggelmann H, de Tribolet N.

Acta Neurochir (Wien). 1990;107(3-4):82-7.

PMID:
2077857
35.

Use of a glucocorticoid-inducible promoter for expression of herpes simplex virus type 1 glycoprotein gC1, a cytotoxic protein in mammalian cells.

Friedman HM, Yee A, Diggelmann H, Hastings JC, Tal-Singer R, Seidel-Dugan CA, Eisenberg RJ, Cohen GH.

Mol Cell Biol. 1989 Jun;9(6):2303-14.

36.

Dual function of a nuclear factor I binding site in MMTV transcription regulation.

Buetti E, Kühnel B, Diggelmann H.

Nucleic Acids Res. 1989 Apr 25;17(8):3065-78.

37.

Alterations in the U3 region of the long terminal repeat of an infectious thymotropic type B retrovirus.

Ball JK, Diggelmann H, Dekaban GA, Grossi GF, Semmler R, Waight PA, Fletcher RF.

J Virol. 1988 Aug;62(8):2985-93.

38.

Prognostic implications of expression of the cellular genes myc, fos, Ha-ras and Ki-ras in colon carcinoma.

Monnat M, Tardy S, Saraga P, Diggelmann H, Costa J.

Int J Cancer. 1987 Sep 15;40(3):293-9.

PMID:
3040597
41.
42.
43.
44.

[Mechanisms of activation and function of oncogenes].

Diggelmann H.

Schweiz Med Wochenschr. 1984 Oct 6;114(40):1364-9. French.

PMID:
6494871
46.
47.

Mouse mammary tumour virus related sequences are present in human DNA.

May FE, Westley BR, Rochefort H, Buetti E, Diggelmann H.

Nucleic Acids Res. 1983 Jun 25;11(12):4127-39.

50.

Isolation and analysis of genomic DNA clones encoding the third component of mouse complement.

Wiebauer K, Domdey H, Diggelmann H, Fey G.

Proc Natl Acad Sci U S A. 1982 Dec;79(23):7077-81.

Supplemental Content

Loading ...
Support Center